(Q35751743)

10 August 2017

1 reference

title

Fumaric acid esters, their place in the treatment of psoriasis (English)

1 reference

10 August 2017

A D Ormerod

1

1 reference

10 August 2017

U Mrowietz

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

British Journal of Dermatology

10 August 2017

published in

1 reference

10 August 2017

volume

150

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

630-632

1 reference

Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0007-0963.2004.05903.X

Addition of pentoxifylline could reduce the side effects of fumaric acid esters in the treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0007-0963.2004.05903.X

Inhibition of dendritic cell differentiation by fumaric acid esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0007-0963.2004.05903.X

Dimethylfumarate inhibits TNF-induced nuclear entry of NF-kappa B/p65 in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0007-0963.2004.05903.X

Dimethylfumarate is an inhibitor of cytokine-induced nuclear translocation of NF-kappa B1, but not RelA in normal human dermal fibroblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0007-0963.2004.05903.X

10.1111/J.0007-0963.2004.05903.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference